多发性骨髓瘤的基本治疗策略  

Core treatment strategy for multiple myeloma in China

作　　者：陈世伦[1] 

机构地区：[1]首都医科大学附属北京朝阳医院京西院区血液科北京市多发性骨髓瘤临床研究中心,北京100043

出　　处：《白血病．淋巴瘤》2008年第5期323-324,共2页Journal of Leukemia & Lymphoma

摘　　要：随着医学诊断水平的提高和人口的老龄化，多发性骨髓瘤（MM）的发病率也逐年提高。当前MM仍被认为是一种不可治愈的疾病，因此，努力提高诊断水平，认真地研究合理的治疗方法，特别是近年来倡导的新药与传统药物的联合治疗、危险分层的治疗以及个体化治疗，是延长生存期、减少并发症、改善预后的重要途径。The incidence of multiple myeloma （MM） has increased each year with the improving medical diagnostic technology and ageing population. The MM is still an incurable disease at present. Following the improving diagnostic technology, serious study of the therapeutic regimen, combination therapy of new drugs with conditional drugs, risk-adapted therapy in MM and individualized treatment, it is an important strategy to prolong the survival, reduce the complication and improve the prognosis.

关 键 词：多发性骨髓肿瘤 治疗学 

分 类 号：R733.3[医药卫生—肿瘤]